Successful use of guselkumab in the treatment of severe hidradenitis suppurativa

Clin Exp Dermatol. 2020 Jul;45(5):618-619. doi: 10.1111/ced.14199. Epub 2020 Mar 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Female
  • Hidradenitis Suppurativa / complications
  • Hidradenitis Suppurativa / drug therapy*
  • Hidradenitis Suppurativa / immunology
  • Humans
  • Interleukin-12 / metabolism
  • Interleukin-23 / metabolism
  • Latent Tuberculosis / complications

Substances

  • Antibodies, Monoclonal, Humanized
  • Interleukin-23
  • guselkumab
  • Interleukin-12